We pride ourselves on our innovation outcomes. Organisations across all sectors can accelerate the translation of ideas into tangible goods and services when they include leading thinkers and doers in the process. At the University of Birmingham, businesses come to us to access the intellectual property, know-how and expertise embedded in our research community, through consultancy with our academics or collaborative research. These interactions are truly two-way, supported by dedicated account management teams, many drawn from industry ensuring businesses develop cutting-edge products and services and that our academic research continues to be informed by real-world needs.
Making the expertise and knowledge of our academics available to industry, non-profit organisations, public sector organisations and governments.
We welcome approaches from senior managers looking for executive or non-executive positions, and from investors who want to keep in touch with existing or emerging spinouts.
Find out about our technologies that are available for commercial development and their applications.
We are part of the Midlands Innovation group of universities building a spin-out and start-up ecosystem to significantly increase the innovation productivity of the region. Note: MICRA grant funding is now closed.
Birmingham Research Park provides secure, high-quality office space, conference facilities and virtual tenancies, in a community of research-led companies.
We are experts in providing training and tailor-made support for academic researchers interested in commercialising their research or becoming entrepreneurs and will support your business journey whatever stage you are at.
An end-to-end service for academic innovators, including practical and financial support for proof of concept studies and market research, training, incubation services and facilities.
News
Posted 18 November 2021
Vacancy IP Business Development Manager
Posted 09 November 2021
Birmingham Biotech Ltd and the University of Birmingham have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against COVID-19.
Posted 02 November 2021
Research shows mass production can make customised PPE for healthcare workers
University of Birmingham Enterprise news
Also in 'University of Birmingham Enterprise'